Edmund Dunn serves as Executive at Monte Rosa Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Edmund Dunn has executed 2 insider transactions totaling $11.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 5, 2024 involved selling 1,610 shares valued at $6.2K.
Edmund Dunn currently holds 13,944 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edmund Dunn has been a net seller of GLUE stock. They have purchased $0 and sold $11.0K worth of shares.
Edmund Dunn's most recent insider trade was on Jul 5, 2024, when they sold 1,610 shares at $3.83 per share.
Get notified when new Form 4 filings are submitted
| $4.04 |
| Discretionary |